PDT Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.25M Buy
+8,400
New +$3.12M 0.17% 185
2022
Q3
Sell
-2,374
Closed -$1.15M 904
2022
Q2
$1.15M Buy
+2,374
New +$1.17M 0.1% 349
2020
Q3
Sell
-3,614
Closed -$950K 756
2020
Q2
$950K Buy
+3,614
New +$964K 0.06% 289
2020
Q1
Sell
-1,515
Closed -$458K 711
2019
Q4
$458K Buy
+1,515
New +$417K 0.03% 437
2015
Q4
Sell
-136,532
Closed -$19.1M 555
2015
Q3
$19.1M Buy
136,532
+119,889
+720% +$18M 0.43% 46
2015
Q2
$2.73M Sell
16,643
-14,194
-46% -$2.27M 0.07% 325
2015
Q1
$4.76M Buy
+30,837
New +$4.39M 0.12% 210
2014
Q3
Sell
-133,720
Closed -$14.4M 1379
2014
Q2
$14.4M Sell
133,720
-117,867
-47% -$12.1M 0.38% 41
2014
Q1
$25M Buy
251,587
+245,487
+4,024% +$22.2M 0.6% 20
2013
Q4
$564K Buy
6,100
+400
+7% +$35.5K 0.07% 372
2013
Q3
$477K Hold
5,700
0.01% 1062
2013
Q2
$466K Buy
+5,700
New +$427K 0.01% 1086

Other funds holding ELV

PDT Partners's ELV Position: Q2 2026 in Review

PDT Partners opened a new position in Elevance Health (ELV) in Q2 2026: 8,400 shares worth $3.25M. The stake represents 0.17% of the portfolio and ranks #185 among its holdings. This is a return to the name: PDT Partners previously reported a position in ELV as recently as Q2 2022.

PDT Partners first reported a position in ELV in Q2 2013 and has held it in 12 quarters since. The position peaked at $25M in Q1 2014. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • PDT Partners held 8,400 shares of Elevance Health worth $3.25M as of Q2 2026.
  • Elevance Health was a new PDT Partners position in Q2 2026.
  • Elevance Health made up 0.17% of PDT Partners's portfolio in Q2 2026, its #185 holding.
  • PDT Partners first reported a position in Elevance Health in Q2 2013 and has held it in 12 quarters since.
  • PDT Partners's Elevance Health position peaked at $25M in Q1 2014.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on PDT Partners's 13F filing for Q2 2026, filed 14 Aug 2026.